Literature DB >> 3335927

Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells.

J C Maublant1, P Gachon, N Moins.   

Abstract

Hexakis (2-methoxy isobutylisonitrile) technetium-99m [(99mTc]MIBI), a new tracer of myocardial blood flow, was compared with 201TI CI in cultures of myocardial cells of newborn rats. The kinetics of uptake and release of both tracers were assessed in basal conditions and in the presence of 5 mM cyanide, an inhibitor of the respiratory chain, 0.1 mM iodoacetate, an inhibitor of glycolysis, 10 microM ouabain, an inhibitor of the Na-K ATPase, or with various pH values. The amplitude and frequency of contractions of the cells were also monitored in the same conditions. Results show that the washin and washout kinetics of [99mTc]MIBI are slower than 201TI(T1/2) of the washout curves were, respectively, of 28 min and 6 min). The kinetics of release of both tracers were not influenced by any of the inhibitors. There was a strong effect of the pH on the 201TI uptake only. Moreover 201TI uptake was decreased by 34% in the presence of cyanide plus iodoacetate. Otherwise the uptakes of 201TI and [99mTc]MIBI were not decreased by any of the drugs. The cellular contractility was significantly diminished by cyanide and it was abolished by cyanide plus iodoacetate. It is concluded that (a) impaired contractility can be associated with normal 201TI and [99mTc]MIBI kinetics in myocardial cells in culture, (b) that 201TI uptake may depend on the level of ATP devoted to the maintenance of membrane integrity, (c) that [99mTc]MIBI shows slower kinetics but is less sensitive to metabolic inhibitors than 201TI.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335927

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  16 in total

1.  Three-dimensional display of myocardial perfusion: detection of ischemic lesions using a new image subtraction method.

Authors:  P P Ferretti; G Borasi; D Salvo; D Serafini; A Versari
Journal:  Eur J Nucl Med       Date:  1990

2.  Same day injections of Tc-99m methoxy isobutyl isonitrile (hexamibi) for myocardial tomographic imaging: comparison between rest-stress and stress-rest injection sequences.

Authors:  R Taillefer; A Gagnon; L Laflamme; J Grégoire; J Léveillé; D C Phaneuf
Journal:  Eur J Nucl Med       Date:  1989

3.  Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells.

Authors:  J C Maublant; N Moins; P Gachon
Journal:  Eur J Nucl Med       Date:  1989

4.  Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics.

Authors:  Z Liu; G Johnson; D Beju; R D Okada
Journal:  J Nucl Cardiol       Date:  2001 Nov-Dec       Impact factor: 5.952

5.  Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.

Authors:  J Y Choi; S E Kim; H J Shin; B T Kim; J H Kim
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

6.  Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration.

Authors:  A Peix; A López; F Ponce; J Morales; A R de la Vega; C S Chesa; A M Maltas; D García-Barreto
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

7.  99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model.

Authors:  Zhonglin Liu; David R Okada; Gerald Johnson; Sonia D Hocherman; Delia Beju; Robert D Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-19       Impact factor: 9.236

8.  Technetium-99m teboroxime scintigraphy. Clinical experience in patients referred for myocardial perfusion evaluation.

Authors:  L Bontemps; X Geronicola-Trapali; Y Sayegh; O Delmas; R Itti; X André-Fouët
Journal:  Eur J Nucl Med       Date:  1991

9.  Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent.

Authors:  Padmaja Yalamanchili; Eric Wexler; Megan Hayes; Ming Yu; Jody Bozek; Mikhail Kagan; Heike S Radeke; Michael Azure; Ajay Purohit; David S Casebier; Simon P Robinson
Journal:  J Nucl Cardiol       Date:  2007-10-22       Impact factor: 5.952

10.  Clinical experience with technetium-99m teboroxime scintigraphy in patients referred for myocardial perfusion evaluation.

Authors:  R Itti; L Bontemps; Y Sayegh; O Delmas; X Geronicola; X Andre-Fouët
Journal:  Int J Card Imaging       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.